Dose-ranging study of SCH34117 in the treatment of patients with seasonal allergic rhinitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32042139

Enrollment

1026

Registered

2002-08-02

Start date

1998-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seasonal allergic rhinitis Respiratory Diseases of upper respiratory tract

Interventions

Patients randomly assigned once-daily (QD) SCH34117 at doses of 2.5, 5, 7.5, 10, or 20 mg versus placebo for two weeks.

Eligibility

Inclusion criteria

Inclusion criteria: Subjects 12 years or older with a two-year documented history of seasonal allergic rhinitis and otherwise in good health

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026